AUG 06, 2016 02:04 PM PDT

New Immunotherapy Strategy Against Lymphoma

WRITTEN BY: Xuan Pham
In an effort to nip lymphomas before it becomes lethal to patients, scientists at the University of Geneva have developed a new way to block the cancer’s migration. This process locks the cancer cells and prevents spread to the lymphatic system.

Blocking the migration of cancer cells to destroy them | Image: University of Geneva
 
Cancer of the blood can be a frightening diagnosis. Lymphomas occur when lymphocytes (white blood cells) turn malignant. It usually starts in a lymphoid organ, such as the lymph node, spleen, or bone marrow, and then infiltrates other organs and tissues. The Leukemia and Lymphoma Society estimates that over 81,000 new patients will be diagnosed with lymphoma this year in the U.S.
 
Malignant lymphocytes become dangerous when they circulate in the blood and travel to the lymphatic system. There, the cancerous cells can cause swelling of the lymph nodes and disrupt normal metabolic processes.
 
But before they arrive at the lymph system, scientists say the cancerous lymphocytes are not yet dangerous. “Since they cannot survive in the blood for long, these malignant cells are compelled to find a more accommodating environment - such as the lymphatic system - where they can proliferate,” said Thomas Matthes, professor at the University of Geneva and senior study author. “We decided to focus on this Achilles heel by containing them in the blood so as to prevent any resulting harm,” he further explained.
 

 Indeed, the team learned that cancerous lymphocytes leave the confines of the blood vessels by expressing a surface protein known as JAM-C. This protein acts like a pass, allowing the mutant cells to get through the endothelial cells that line blood vessels.
 
The team then developed an antibody against JAM-C. This protein targets JAM-C and essentially makes the surface protein unrecognizable to the endothelial cell guards. Essentially, the antibody, named H225, revoked the mutant cells’ ability to migrate out of blood vessels.
 
In experiments, the team showed H225 decreased the cancer cells’ migration to the lymphs by over 50 percent. “H225 also significantly limited cell proliferation, even when tumor cells had already settled in the lymphatic system. In our mice, we observed the nearly-complete disappearance of already-present tumor cells in the organs,” Matthes added.
 
There are nearly 790,000 people currently living with, or recovering from, lymphoma in the U.S. The survival rate from lymphoma is increasing, but only thanks to new research such as this that exploit the cancer’s weaknesses to patients’ advantage. 

Additional source: University of Geneva press release
 
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 14, 2018
Cancer
AUG 14, 2018
Using Arsenic to Enhance Cancer Therapies Beyond Leukemia
An already existing combination of arsenic and all-trans retinoic acid is found to inhibit a key signaling pathway that exerts broad effect on oncogenic processes for some solid tumors....
AUG 26, 2018
Cancer
AUG 26, 2018
Can antireflux surgery prevent Esophageal cancer?
Heartburn or gastroesophageal reflux disease (GERD) is a widespread health problem affecting 10 to 20% of adults in Western populations. If GERD left untre...
SEP 04, 2018
Cancer
SEP 04, 2018
Metal beads that could help reduce chemotherapy side effects in brain tumor
Brain tumors are one of the most challenging types of cancers to treat. Only 1 in 7 patients will survive the disease, and those survivors will usually suffer from lots of side effects becaus...
NOV 02, 2018
Cell & Molecular Biology
NOV 02, 2018
Natural Molecule Enables Obese Mice to Shed Weight
A molecule that has been a focus of cancer research has been found to be a significant regulator of metabolism....
NOV 06, 2018
Genetics & Genomics
NOV 06, 2018
New Gene is Implicated in a Rare Cancer
Rodents are known as common research models, but zebrafish have been gaining ground as an attractive alternative for many reasons....
DEC 06, 2018
Microbiology
DEC 06, 2018
A Bacterial Protein can Encourage Cancer Development
It's been suggested that a fifth of all cancers are caused by microbial infections, and new work indicates that the estimate is probably low....
Loading Comments...